Fate Therapeutics, Inc. (NASDAQ:FATE – Get Rating)’s share price dropped 9.3% on Tuesday . The stock traded as low as $5.72 and last traded at $5.77. Approximately 679,137 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 3,473,137 shares. The stock had previously closed at $6.36. Analyst Upgrades […]